The effect of peripheral administration of growth hormone on AD-like cognitive deficiency in NBM-lesioned rats

This study aimed to evaluate the peripheral administration of growth hormone (GH) on AD-like cognitive deficiency in NBM-lesioned rats induced by ibotenic acid (5 μg/μl, in each side). Forty-eight male Wistar rats (20–24 months old; weighing 330 ± 30 g) randomly divided into six groups ( n = 8). The...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuroscience letters 2009-11, Vol.466 (1), p.47-51
Hauptverfasser: Doulah, A.H., Rohani, A. Haeri, Haddad, M. Khaksari, Motamedi, F., Farbood, Y., Badavi, M., Malek, M., Sarkaki, A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 51
container_issue 1
container_start_page 47
container_title Neuroscience letters
container_volume 466
creator Doulah, A.H.
Rohani, A. Haeri
Haddad, M. Khaksari
Motamedi, F.
Farbood, Y.
Badavi, M.
Malek, M.
Sarkaki, A.
description This study aimed to evaluate the peripheral administration of growth hormone (GH) on AD-like cognitive deficiency in NBM-lesioned rats induced by ibotenic acid (5 μg/μl, in each side). Forty-eight male Wistar rats (20–24 months old; weighing 330 ± 30 g) randomly divided into six groups ( n = 8). The groups include control group, which were intact rats; n-L + GH group: non-lesioned rats with GH treatment (1 mg/kg, 9.00 am, for 10 consecutive days); n-L + Veh group: non-lesioned rats with vehicle treatment; L group: NBM-lesioned rats; L + GH group: NBM-lesioned rats with GH treatment and L + Veh group: NBM-lesioned rats with same volume of vehicle treatment. Peripheral administration of GH in control had no effect on learning and memory, while in L + GH group produced a significant enhancement in spatial learning and memory comparing to L and L + Veh groups. The percent of time spent in goal quarter during probe trial has decreased significantly in L and L + Veh groups compared to n-L groups. While it has increased significantly in L + GH group compared to L and L + Veh groups. No significant difference in percent of time spent was seen between the control and n-L groups. The GH has known as a mediate that effect through IGF-1. As the IGF-1 itself is earlier shown to improve cognitive function it is likely that the observed effect of GH is mediated through release of IGF-1 from peripheral tissue into the circulation for further transport across the BBB. This mechanism may result in the improvement of learning and memory in rats with NBM lesion.
doi_str_mv 10.1016/j.neulet.2009.09.016
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733601473</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0304394009012221</els_id><sourcerecordid>733601473</sourcerecordid><originalsourceid>FETCH-LOGICAL-c422t-ae05743765a72ff40d7a051598f88be9a2e9d100410bb491c85f62954254ca813</originalsourceid><addsrcrecordid>eNp9kU9v1DAQxS0EotuFb4CQL7SnbMeOncQXpNLyp1KBSzlbXmfc9ZLYi50t6rfHYVdwqzTSSPZvnt7MI-QNgxUD1lxsVwH3A04rDqBWc7HmGVmwruVVq1r-nCygBlHVSsAJOc15CwCSSfGSnDDVNrKp5YKEuw1SdA7tRKOjO0x-t8FkBmr60Qefp2QmH8P8eZ_i72lDNzGNMSAtj5fX1eB_IrXxPvjJPyDt0XnrMdhH6gP99uFrNWAu89jTIpRfkRfODBlfH_uS_Pj08e7qS3X7_fPN1eVtZQXnU2UQZCvqYtK03DkBfWtm76pzXbdGZTiqngEIBuu1UMx20jVcScGlsKZj9ZKcH3R3Kf7aY5706LPFYTAB4z7rtq4bYKK0JTl7kuQMil4HBRQH0KaYc0Knd8mPJj1qBnpORG_1IRE9J6LnYk0Ze3vU369H7P8PHSMowLsjYLI1g0smWJ__cZxDKxs1r_T-wGG524PHpPPfQ2PvU0lP99E_7eQP346rEw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>21081380</pqid></control><display><type>article</type><title>The effect of peripheral administration of growth hormone on AD-like cognitive deficiency in NBM-lesioned rats</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Doulah, A.H. ; Rohani, A. Haeri ; Haddad, M. Khaksari ; Motamedi, F. ; Farbood, Y. ; Badavi, M. ; Malek, M. ; Sarkaki, A.</creator><creatorcontrib>Doulah, A.H. ; Rohani, A. Haeri ; Haddad, M. Khaksari ; Motamedi, F. ; Farbood, Y. ; Badavi, M. ; Malek, M. ; Sarkaki, A.</creatorcontrib><description>This study aimed to evaluate the peripheral administration of growth hormone (GH) on AD-like cognitive deficiency in NBM-lesioned rats induced by ibotenic acid (5 μg/μl, in each side). Forty-eight male Wistar rats (20–24 months old; weighing 330 ± 30 g) randomly divided into six groups ( n = 8). The groups include control group, which were intact rats; n-L + GH group: non-lesioned rats with GH treatment (1 mg/kg, 9.00 am, for 10 consecutive days); n-L + Veh group: non-lesioned rats with vehicle treatment; L group: NBM-lesioned rats; L + GH group: NBM-lesioned rats with GH treatment and L + Veh group: NBM-lesioned rats with same volume of vehicle treatment. Peripheral administration of GH in control had no effect on learning and memory, while in L + GH group produced a significant enhancement in spatial learning and memory comparing to L and L + Veh groups. The percent of time spent in goal quarter during probe trial has decreased significantly in L and L + Veh groups compared to n-L groups. While it has increased significantly in L + GH group compared to L and L + Veh groups. No significant difference in percent of time spent was seen between the control and n-L groups. The GH has known as a mediate that effect through IGF-1. As the IGF-1 itself is earlier shown to improve cognitive function it is likely that the observed effect of GH is mediated through release of IGF-1 from peripheral tissue into the circulation for further transport across the BBB. This mechanism may result in the improvement of learning and memory in rats with NBM lesion.</description><identifier>ISSN: 0304-3940</identifier><identifier>EISSN: 1872-7972</identifier><identifier>DOI: 10.1016/j.neulet.2009.09.016</identifier><identifier>PMID: 19765635</identifier><identifier>CODEN: NELED5</identifier><language>eng</language><publisher>Shannon: Elsevier Ireland Ltd</publisher><subject>Alzheimer Disease - drug therapy ; Alzheimer Disease - pathology ; Alzheimer Disease - psychology ; Animals ; Basal Nucleus of Meynert - pathology ; Biological and medical sciences ; Cognition Disorders - drug therapy ; Cognition Disorders - pathology ; Cognition Disorders - psychology ; Disease Models, Animal ; Fundamental and applied biological sciences. Psychology ; Growth hormone ; Growth Hormone - administration &amp; dosage ; Growth Hormone - therapeutic use ; Ibotenic acid ; Injections, Subcutaneous ; Learning - drug effects ; Male ; Maze Learning - drug effects ; Memory - drug effects ; Morris water maze ; NBM ; Rats ; Rats, Wistar ; Vertebrates: nervous system and sense organs</subject><ispartof>Neuroscience letters, 2009-11, Vol.466 (1), p.47-51</ispartof><rights>2009 Elsevier Ireland Ltd</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c422t-ae05743765a72ff40d7a051598f88be9a2e9d100410bb491c85f62954254ca813</citedby><cites>FETCH-LOGICAL-c422t-ae05743765a72ff40d7a051598f88be9a2e9d100410bb491c85f62954254ca813</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.neulet.2009.09.016$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,45974</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=22075691$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19765635$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Doulah, A.H.</creatorcontrib><creatorcontrib>Rohani, A. Haeri</creatorcontrib><creatorcontrib>Haddad, M. Khaksari</creatorcontrib><creatorcontrib>Motamedi, F.</creatorcontrib><creatorcontrib>Farbood, Y.</creatorcontrib><creatorcontrib>Badavi, M.</creatorcontrib><creatorcontrib>Malek, M.</creatorcontrib><creatorcontrib>Sarkaki, A.</creatorcontrib><title>The effect of peripheral administration of growth hormone on AD-like cognitive deficiency in NBM-lesioned rats</title><title>Neuroscience letters</title><addtitle>Neurosci Lett</addtitle><description>This study aimed to evaluate the peripheral administration of growth hormone (GH) on AD-like cognitive deficiency in NBM-lesioned rats induced by ibotenic acid (5 μg/μl, in each side). Forty-eight male Wistar rats (20–24 months old; weighing 330 ± 30 g) randomly divided into six groups ( n = 8). The groups include control group, which were intact rats; n-L + GH group: non-lesioned rats with GH treatment (1 mg/kg, 9.00 am, for 10 consecutive days); n-L + Veh group: non-lesioned rats with vehicle treatment; L group: NBM-lesioned rats; L + GH group: NBM-lesioned rats with GH treatment and L + Veh group: NBM-lesioned rats with same volume of vehicle treatment. Peripheral administration of GH in control had no effect on learning and memory, while in L + GH group produced a significant enhancement in spatial learning and memory comparing to L and L + Veh groups. The percent of time spent in goal quarter during probe trial has decreased significantly in L and L + Veh groups compared to n-L groups. While it has increased significantly in L + GH group compared to L and L + Veh groups. No significant difference in percent of time spent was seen between the control and n-L groups. The GH has known as a mediate that effect through IGF-1. As the IGF-1 itself is earlier shown to improve cognitive function it is likely that the observed effect of GH is mediated through release of IGF-1 from peripheral tissue into the circulation for further transport across the BBB. This mechanism may result in the improvement of learning and memory in rats with NBM lesion.</description><subject>Alzheimer Disease - drug therapy</subject><subject>Alzheimer Disease - pathology</subject><subject>Alzheimer Disease - psychology</subject><subject>Animals</subject><subject>Basal Nucleus of Meynert - pathology</subject><subject>Biological and medical sciences</subject><subject>Cognition Disorders - drug therapy</subject><subject>Cognition Disorders - pathology</subject><subject>Cognition Disorders - psychology</subject><subject>Disease Models, Animal</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Growth hormone</subject><subject>Growth Hormone - administration &amp; dosage</subject><subject>Growth Hormone - therapeutic use</subject><subject>Ibotenic acid</subject><subject>Injections, Subcutaneous</subject><subject>Learning - drug effects</subject><subject>Male</subject><subject>Maze Learning - drug effects</subject><subject>Memory - drug effects</subject><subject>Morris water maze</subject><subject>NBM</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Vertebrates: nervous system and sense organs</subject><issn>0304-3940</issn><issn>1872-7972</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU9v1DAQxS0EotuFb4CQL7SnbMeOncQXpNLyp1KBSzlbXmfc9ZLYi50t6rfHYVdwqzTSSPZvnt7MI-QNgxUD1lxsVwH3A04rDqBWc7HmGVmwruVVq1r-nCygBlHVSsAJOc15CwCSSfGSnDDVNrKp5YKEuw1SdA7tRKOjO0x-t8FkBmr60Qefp2QmH8P8eZ_i72lDNzGNMSAtj5fX1eB_IrXxPvjJPyDt0XnrMdhH6gP99uFrNWAu89jTIpRfkRfODBlfH_uS_Pj08e7qS3X7_fPN1eVtZQXnU2UQZCvqYtK03DkBfWtm76pzXbdGZTiqngEIBuu1UMx20jVcScGlsKZj9ZKcH3R3Kf7aY5706LPFYTAB4z7rtq4bYKK0JTl7kuQMil4HBRQH0KaYc0Knd8mPJj1qBnpORG_1IRE9J6LnYk0Ze3vU369H7P8PHSMowLsjYLI1g0smWJ__cZxDKxs1r_T-wGG524PHpPPfQ2PvU0lP99E_7eQP346rEw</recordid><startdate>20091127</startdate><enddate>20091127</enddate><creator>Doulah, A.H.</creator><creator>Rohani, A. Haeri</creator><creator>Haddad, M. Khaksari</creator><creator>Motamedi, F.</creator><creator>Farbood, Y.</creator><creator>Badavi, M.</creator><creator>Malek, M.</creator><creator>Sarkaki, A.</creator><general>Elsevier Ireland Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>20091127</creationdate><title>The effect of peripheral administration of growth hormone on AD-like cognitive deficiency in NBM-lesioned rats</title><author>Doulah, A.H. ; Rohani, A. Haeri ; Haddad, M. Khaksari ; Motamedi, F. ; Farbood, Y. ; Badavi, M. ; Malek, M. ; Sarkaki, A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c422t-ae05743765a72ff40d7a051598f88be9a2e9d100410bb491c85f62954254ca813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Alzheimer Disease - drug therapy</topic><topic>Alzheimer Disease - pathology</topic><topic>Alzheimer Disease - psychology</topic><topic>Animals</topic><topic>Basal Nucleus of Meynert - pathology</topic><topic>Biological and medical sciences</topic><topic>Cognition Disorders - drug therapy</topic><topic>Cognition Disorders - pathology</topic><topic>Cognition Disorders - psychology</topic><topic>Disease Models, Animal</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Growth hormone</topic><topic>Growth Hormone - administration &amp; dosage</topic><topic>Growth Hormone - therapeutic use</topic><topic>Ibotenic acid</topic><topic>Injections, Subcutaneous</topic><topic>Learning - drug effects</topic><topic>Male</topic><topic>Maze Learning - drug effects</topic><topic>Memory - drug effects</topic><topic>Morris water maze</topic><topic>NBM</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Vertebrates: nervous system and sense organs</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Doulah, A.H.</creatorcontrib><creatorcontrib>Rohani, A. Haeri</creatorcontrib><creatorcontrib>Haddad, M. Khaksari</creatorcontrib><creatorcontrib>Motamedi, F.</creatorcontrib><creatorcontrib>Farbood, Y.</creatorcontrib><creatorcontrib>Badavi, M.</creatorcontrib><creatorcontrib>Malek, M.</creatorcontrib><creatorcontrib>Sarkaki, A.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Neuroscience letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Doulah, A.H.</au><au>Rohani, A. Haeri</au><au>Haddad, M. Khaksari</au><au>Motamedi, F.</au><au>Farbood, Y.</au><au>Badavi, M.</au><au>Malek, M.</au><au>Sarkaki, A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The effect of peripheral administration of growth hormone on AD-like cognitive deficiency in NBM-lesioned rats</atitle><jtitle>Neuroscience letters</jtitle><addtitle>Neurosci Lett</addtitle><date>2009-11-27</date><risdate>2009</risdate><volume>466</volume><issue>1</issue><spage>47</spage><epage>51</epage><pages>47-51</pages><issn>0304-3940</issn><eissn>1872-7972</eissn><coden>NELED5</coden><abstract>This study aimed to evaluate the peripheral administration of growth hormone (GH) on AD-like cognitive deficiency in NBM-lesioned rats induced by ibotenic acid (5 μg/μl, in each side). Forty-eight male Wistar rats (20–24 months old; weighing 330 ± 30 g) randomly divided into six groups ( n = 8). The groups include control group, which were intact rats; n-L + GH group: non-lesioned rats with GH treatment (1 mg/kg, 9.00 am, for 10 consecutive days); n-L + Veh group: non-lesioned rats with vehicle treatment; L group: NBM-lesioned rats; L + GH group: NBM-lesioned rats with GH treatment and L + Veh group: NBM-lesioned rats with same volume of vehicle treatment. Peripheral administration of GH in control had no effect on learning and memory, while in L + GH group produced a significant enhancement in spatial learning and memory comparing to L and L + Veh groups. The percent of time spent in goal quarter during probe trial has decreased significantly in L and L + Veh groups compared to n-L groups. While it has increased significantly in L + GH group compared to L and L + Veh groups. No significant difference in percent of time spent was seen between the control and n-L groups. The GH has known as a mediate that effect through IGF-1. As the IGF-1 itself is earlier shown to improve cognitive function it is likely that the observed effect of GH is mediated through release of IGF-1 from peripheral tissue into the circulation for further transport across the BBB. This mechanism may result in the improvement of learning and memory in rats with NBM lesion.</abstract><cop>Shannon</cop><pub>Elsevier Ireland Ltd</pub><pmid>19765635</pmid><doi>10.1016/j.neulet.2009.09.016</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0304-3940
ispartof Neuroscience letters, 2009-11, Vol.466 (1), p.47-51
issn 0304-3940
1872-7972
language eng
recordid cdi_proquest_miscellaneous_733601473
source MEDLINE; Elsevier ScienceDirect Journals
subjects Alzheimer Disease - drug therapy
Alzheimer Disease - pathology
Alzheimer Disease - psychology
Animals
Basal Nucleus of Meynert - pathology
Biological and medical sciences
Cognition Disorders - drug therapy
Cognition Disorders - pathology
Cognition Disorders - psychology
Disease Models, Animal
Fundamental and applied biological sciences. Psychology
Growth hormone
Growth Hormone - administration & dosage
Growth Hormone - therapeutic use
Ibotenic acid
Injections, Subcutaneous
Learning - drug effects
Male
Maze Learning - drug effects
Memory - drug effects
Morris water maze
NBM
Rats
Rats, Wistar
Vertebrates: nervous system and sense organs
title The effect of peripheral administration of growth hormone on AD-like cognitive deficiency in NBM-lesioned rats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T06%3A58%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20effect%20of%20peripheral%20administration%20of%20growth%20hormone%20on%20AD-like%20cognitive%20deficiency%20in%20NBM-lesioned%20rats&rft.jtitle=Neuroscience%20letters&rft.au=Doulah,%20A.H.&rft.date=2009-11-27&rft.volume=466&rft.issue=1&rft.spage=47&rft.epage=51&rft.pages=47-51&rft.issn=0304-3940&rft.eissn=1872-7972&rft.coden=NELED5&rft_id=info:doi/10.1016/j.neulet.2009.09.016&rft_dat=%3Cproquest_cross%3E733601473%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=21081380&rft_id=info:pmid/19765635&rft_els_id=S0304394009012221&rfr_iscdi=true